HYDRINITY Introduces First Non-Irritating Retinoid: A Clinical Revolution
HYDRINITY Accelerated Skin Science has made a significant breakthrough in skincare, as revealed in a recent clinical study published in the Journal of Cosmetic Dermatology. The study highlights the efficacy of their innovative retinal, encapsulated in biomimetic exosomes, in enhancing photodamaged skin with zero reported irritation.
The 12-week clinical study involved 20 women, aged between 35 and 65, with mild-to-moderate photodamage. The participants applied HYDRINITY RetaXome™ Daily Retinal Hydrator every night and showed consistent improvements at each evaluation stage. The results were impressive:
- 68% improvement in erythema
- 56% improvement in skin tone
- 63% enhancement in texture by the end of week 12
This innovative product uses a specially engineered biomimetic exosome platform to encapsulate retinal for a precise, controlled release. It’s further enhanced with the brand’s proprietary Supercharged Hyaluronic Acid. Since its launch in 2022, HYDRINITY has swiftly expanded into over 4,000 professional U.S. practices and 32 countries worldwide, establishing a new benchmark in performance-driven skincare.